BENZYL-N-(TERT.-BUTOXYCARBONYL)-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-ESTER
Compound with spectra: 1 NMR
![BENZYL-N-(TERT.-BUTOXYCARBONYL)-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-ESTER](/api/compound/KiWZbobP8gW.png?ph=true&h=300&w=458 "BENZYL-N-(TERT.-BUTOXYCARBONYL)-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-ESTER")
| SpectraBase Compound ID | KiWZbobP8gW |
|---|---|
| InChI | InChI=1S/C23H33N3O8/c1-23(2,3)34-22(31)24-13-12-19(28)26-17(21(30)32-4)10-11-18(27)25-14-20(29)33-15-16-8-6-5-7-9-16/h5-9,17H,10-15H2,1-4H3,(H,24,31)(H,25,27)(H,26,28)/t17-/m1/s1 |
| InChIKey | QWLNEMSXBZNQLW-QGZVFWFLSA-N |
| Mol Weight | 479.5 g/mol |
| Molecular Formula | C23H33N3O8 |
| Exact Mass | 479.226765 g/mol |
| Enantiomer InChIKey | QWLNEMSXBZNQLW-KRWDZBQOSA-N |
| Racemate InChIKey | QWLNEMSXBZNQLW-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
L-N,N-SUCCINYLDIGLUTAMIC ACID, TETRABENZYL ESTER
2-Decanoylamino-pentanedioic acid 5-allyl ester 1-benzyl ester
T-Butoxycarbonyl-lysyl(T-butoxycarbonyl)-glycine benzyl ester
(2S)-2-(tert-butoxycarbonylamino)-5-keto-capric acid benzyl ester
Pentanoic acid, 5-[(2-methoxy-1-methyl-2-oxoethyl)amino]-5-oxo-3-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, [S-(R*,R*)]-
Dibenzyl 2-([(benzyloxy)carbonyl]amino)pentanedioate
T-Butoxycarbonyl-lysyl(T-butoxycarbonyl)-T-glycine benzyl ester
Benzyl 2(S)-[(tert-butoxycarbonyl)amino]-4-oxo-6-methylheptanoate
N-ACETYL-N(DELTA)-BENZYLOXYCARBONYL-L-ORNITHINYL-L-ALANINE-METHYLESTER
T-Butoxycarbonyl-seryl(bzl)-glycine benzyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |